India Glycols Limited (INDIAGLYCO) AI Stock Analysis

• Market Cap: ₹51.77B
• Dividend Yield: 0.58%
• Average Volume (3M): 16.79K
• Price to Earnings (P/E): 21.7
• Beta (1Y): 1.47
• Revenue Growth: 7.46%
• EPS Growth: 33.78%
• Country: IN
• Employees: 1,326
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): 11.83
• Shares Outstanding: 61,923,000
• 10 Day Avg. Volume: 15,950
• 30 Day Avg. Volume: 16,786
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ₹870.00
• Price Target Upside: 4.05% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 57 Neutral
• Price Target: ₹888.00 ▲(6.21% Upside)

India Glycols Limited's overall stock score reflects a combination of mixed financial performance, neutral technical indicators, and moderate valuation. The most significant concerns are declining profit margins and negative free cash flow, which are partially offset by strong revenue growth and effective equity utilization. Technical analysis suggests a cautious outlook, while valuation metrics indicate a fair but not compelling investment opportunity.

India Glycols Limited Business Overview & Revenue Model

Company Description

India Glycols Limited, a green petrochemical company, manufactures and sells industrial chemicals in India. The company operates through Industrial Chemical, Ethyl Alcohol, and Nutraceuticals segments. It offers monoethylene, diethylene, and triethylene glycols; polyethylene glycols; fatty alcohol, acid, and amine ethoxylates; alkyl phenol ethoxylates; castor/natural oil ethoxylates; and ethoxylated and propoxylated co-polymers. The company also provides polysorbates; glycol ethers and acetates; brake fluids and anti-freeze coolants; performance chemicals; natural gums, including guar gums and other hydrocolloid products; extra neutral alcohols/rectified spirits; Indian-made foreign liquor; and alcohol-based hand sanitizers. In addition, it offers natural active pharmaceutical ingredients, standardized botanical and herbal extracts, and spice extracts; and industrial gases, such as liquid oxygen, argon, nitrogen, and carbon dioxide, as well as IGL Steri-gas ethylene oxide and carbon dioxide gas mixtures. The company also exports its products. It serves agrochemical, automotive, detergent, healthcare and food processing, mining, oil and gas, paper, personal care, pharmaceutical, paint and emulsion polymerization, textile, and other industries. The company was formerly known as UP Glycols Limited and changed its name to India Glycols Limited in August 1986. India Glycols Limited was incorporated in 1983 and is headquartered in Noida, India.

How the Company Makes Money

India Glycols Limited generates revenue primarily through the production and sale of chemical products such as glycols, ethoxylates, and performance chemicals. The company leverages its robust manufacturing capabilities and technological expertise to serve a wide range of industries. Glycols, used in automotive antifreeze and coolant applications, and ethoxylates, utilized in detergents and personal care products, are significant contributors to its revenue. Furthermore, the company has a substantial presence in the spirits sector, producing and selling alcohol-based products, which is a vital revenue stream. Strategic partnerships and a strong focus on sustainable and innovative solutions also play a crucial role in its financial performance, enhancing its market reach and customer base.

India Glycols Limited Financial Statement Overview

Summary

India Glycols Limited exhibits a mixed financial picture. Strong revenue growth and effective equity utilization are positive signs. However, declining profit margins, increased leverage, and negative free cash flow highlight areas of concern. The company must focus on enhancing profitability and managing debt to ensure sustainable financial health and mitigate potential risks.

Income Statement

India Glycols Limited shows a mixed performance in its income statement. The gross profit margin is healthy at approximately 26.5% for 2025, indicating efficient cost management. However, the net profit margin saw a decline from 5.3% in 2024 to 6.1% in 2025, showing moderate profitability. Revenue growth was strong in 2024 at 23.3%, but slowed down to 15.3% in 2025. EBIT margin is at 6.5% for 2025, indicating some operational efficiency but room for improvement. Overall, while there are areas of strength, such as revenue growth, declining margins present a challenge.

Balance Sheet

The balance sheet reveals a stable yet cautious financial position. The debt-to-equity ratio increased to 0.84 in 2025, suggesting higher leverage which could heighten financial risk. Return on Equity (ROE) improved to 10.2%, reflecting better utilization of equity. The equity ratio is stable at 36.5%, indicating a reasonable proportion of assets financed by equity. While the company maintains a solid equity base, increasing debt levels pose a potential risk to financial stability.

Cash Flow

Cash flow analysis indicates some challenges, particularly in free cash flow generation which remained negative at -3.98 billion in 2025. The operating cash flow to net income ratio stands at 1.57, which is healthy, suggesting good cash conversion from profits. However, the free cash flow to net income ratio is negative due to high capital expenditures, indicating potential future cash flow constraints. Improving free cash flow generation should be a priority to bolster financial flexibility.

Breakdown	TTM	Dec 2025	Dec 2023	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	37.68B	37.68B	26.51B	32.69B	28.13B	22.48B
Gross Profit	11.37B	9.99B	10.69B	10.55B	8.45B	7.06B
EBITDA	5.44B	5.11B	3.47B	4.28B	4.98B	2.86B
Net Income	2.31B	2.31B	1.25B	1.73B	3.40B	1.32B
Balance Sheet
Total Assets	61.76B	61.76B	48.58B	56.17B	46.31B	41.19B
Cash, Cash Equivalents and Short-Term Investments	774.40M	774.40M	2.83B	746.42M	430.66M	396.11M
Total Debt	18.92B	18.92B	11.12B	13.48B	10.42B	11.37B
Total Liabilities	39.20B	39.20B	29.57B	35.66B	28.58B	29.51B
Stockholders Equity	22.56B	22.56B	19.01B	20.51B	17.92B	11.69B
Cash Flow
Free Cash Flow	0.00	-3.98B	-1.13B	-1.14B	-2.64B	-115.54M
Operating Cash Flow	0.00	3.62B	3.26B	4.39B	1.16B	1.37B
Investing Cash Flow	0.00	-7.36B	-3.30B	-5.03B	764.47M	-1.48B
Financing Cash Flow	0.00	3.54B	-5.10M	899.12M	-1.89B	107.45M

India Glycols Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 836.10
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDIAGLYCO, the sentiment is Negative. The current price of 836.1 is below the 20-day moving average (MA) of 841.29, below the 50-day MA of 854.48, and above the 200-day MA of 760.68, indicating a neutral trend. The MACD of 1.01 indicates Negative momentum. The RSI at 45.91 is Neutral, neither overbought nor oversold. The STOCH value of 38.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:INDIAGLYCO.

India Glycols Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GNFC	68 Neutral	73.65B	13.10	6.96%	3.58%	-9.97%	9.63%
LXCHEM	63 Neutral	58.51B	58.14	5.95%	0.23%	3.62%	-14.41%
SUNFLAG	62 Neutral	48.70B	24.70	1.85%	0.28%	3.63%	35.18%
INDIAGLYCO	57 Neutral	₹51.77B	21.71	―	0.58%	7.46%	33.78%
GUJALKALI	55 Neutral	42.69B	-121.23	-1.08%	2.79%	8.51%	84.67%
CAMLINFINE	46 Neutral	42.17B	-32.89	-15.42%	―	8.06%	19.90%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%